Loading...

Home
ETF
MYGN

MYGN

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

MYGN News

Myriad Genetics Appoints New Chief Technology Officer

Jun 02 2026Newsfilter

Myriad Genetics Unveils New Data on MRD Testing Across Cancer Types

May 27 2026Newsfilter

Myriad Genetics Launches Prolaris + AI Test for Prostate Cancer Prognosis

May 27 2026NASDAQ.COM

Identifying Potentially Profitable Stocks

May 23 2026Yahoo Finance

Myriad Genetics Partners with Jackie Tohn to Promote Hereditary Cancer Testing

May 15 2026Newsfilter

Myriad Genetics Reports Q1 2026 Earnings Miss

May 06 2026seekingalpha

Myriad Genetics Q1 2026 Earnings Call Insights

May 06 2026seekingalpha

Myriad Genetics Q1 Results: Revenue Growth Amid Wider Losses

May 05 2026NASDAQ.COM

Myriad Genetics Q1 Earnings Miss Expectations

May 05 2026seekingalpha

Myriad Genetics to Announce Q1 Earnings on May 5th

May 04 2026seekingalpha

GeneSight Test Enhances Personalized Mental Health Treatment Insights

Apr 30 2026Newsfilter

Myriad Genetics to Present New Research at AACR Annual Meeting

Apr 16 2026Newsfilter

Myriad Genetics Receives Approval for New Test in Japan

Apr 14 2026Newsfilter

Myriad Genetics Presents New Data at SGO Annual Meeting

Apr 09 2026Newsfilter

Myriad Genetics Under Investigation for Possible Securities Fraud

Apr 06 2026Globenewswire

Myriad Genetics Receives FDA Approval for MyChoice CDx Test

Mar 18 2026NASDAQ.COM